Cardiovascular Disease

  • Identify patients at elevated risk for CVD and calculate their 10-year cardiovascular risk using the Framingham Risk Score.
  • Propose a patient-centered initial management plan for primary prevention of CVD and which investigations should be used to do this.
  • Describe an early post-ischemia/infarction management plan including lifestyle changes, medications, psychosocial support, cardiac rehabilitation, etc.
  • Propose a surveillance and management plan for secondary prevention of cardiovascular events in patients with CVD.

Core Resources

Ischemic Heart Disease Management Clinical Card.pdf

Khattab Y, Keegan DA. Ischemic Heart Disease Management. Canadian Family Medicine Clinical Card. 2015. Available at: https://sites.google.com/site/sharcfm/

Cardiovascular Risk.pdf

Payne RA. Cardiovascular risk. British Journal of Clinical Pharmacology. 2012;74(3):396-410. doi:10.1111/j.1365-2125.2012.04219.x.

Secondary Prevention of Coronary artery disease

‘Hall SL, Lorenc T. Secondary prevention of coronary artery disease. Am Fam Physician. 2010; 81(3):289-296

Quality Standard Placemat for Heart Failure

Ontario Health. Quality Standard Placemat for Heart Failure. November 2021.

Supplemental Resources

Acute Coronary Syndrome: Diagnostic Evaluation

Barstow C, Rice M, McDivitt J. Acute Coronary Syndrome: Diagnositc Evaluation. Am Fam Physician. 2017;95(3):170 -177.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update

Jain R, J.A. Stone, G Aggarwal, et al. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update. CMAJ, 194 (43) (2022), pp. E1460-E1480